176 related articles for article (PubMed ID: 35691594)
1. The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.
Patsenker E; Thangapandi VR; Knittelfelder O; Palladini A; Hefti M; Beil-Wagner J; Rogler G; Buch T; Shevchenko A; Hampe J; Stickel F
J Nutr Biochem; 2022 Oct; 108():109081. PubMed ID: 35691594
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 I148M polymorphism and progressive liver disease.
Dongiovanni P; Donati B; Fares R; Lombardi R; Mancina RM; Romeo S; Valenti L
World J Gastroenterol; 2013 Nov; 19(41):6969-78. PubMed ID: 24222941
[TBL] [Abstract][Full Text] [Related]
4. Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
Su H; Haque M; Becker S; Edlund K; Duda J; Wang Q; Reißing J; Marschall HU; Candels LS; Mohamed M; Sjöland W; Liao L; Drexler SA; Strowig T; Rahnenführer J; Hengstler JG; Hatting M; Trautwein C
Liver Int; 2023 Aug; 43(8):1699-1713. PubMed ID: 37073116
[TBL] [Abstract][Full Text] [Related]
5. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Nomair AM; Kandil LS; Nomeir HM; Kandil NS
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
[TBL] [Abstract][Full Text] [Related]
6. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
7. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
8. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Cherubini A; Ostadreza M; Jamialahmadi O; Pelusi S; Rrapaj E; Casirati E; Passignani G; Norouziesfahani M; Sinopoli E; Baselli G; Meda C; Dongiovanni P; Dondossola D; Youngson N; Tourna A; Chokshi S; Bugianesi E; ; Della Torre S; Prati D; Romeo S; Valenti L
Nat Med; 2023 Oct; 29(10):2643-2655. PubMed ID: 37749332
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.
Banini BA; Kumar DP; Cazanave S; Seneshaw M; Mirshahi F; Santhekadur PK; Wang L; Guan HP; Oseini AM; Alonso C; Bedossa P; Koduru SV; Min HK; Sanyal AJ
Hepatology; 2021 Apr; 73(4):1290-1306. PubMed ID: 33131062
[TBL] [Abstract][Full Text] [Related]
10. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
[TBL] [Abstract][Full Text] [Related]
11. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C
Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151
[TBL] [Abstract][Full Text] [Related]
12. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
14. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
Friedrich K; Wannhoff A; Kattner S; Brune M; Hov JR; Weiss KH; Antoni C; Dollinger M; Neumann-Haefelin C; Seufferlein T; Schemmer P; Schirmacher P; Stremmel W; Gotthardt DN
J Gastroenterol Hepatol; 2014; 29(7):1477-84. PubMed ID: 25273282
[TBL] [Abstract][Full Text] [Related]
16. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
Li JZ; Huang Y; Karaman R; Ivanova PT; Brown HA; Roddy T; Castro-Perez J; Cohen JC; Hobbs HH
J Clin Invest; 2012 Nov; 122(11):4130-44. PubMed ID: 23023705
[TBL] [Abstract][Full Text] [Related]
17. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.
Burza MA; Molinaro A; Attilia ML; Rotondo C; Attilia F; Ceccanti M; Ferri F; Maldarelli F; Maffongelli A; De Santis A; Attili AF; Romeo S; Ginanni Corradini S
Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786
[TBL] [Abstract][Full Text] [Related]
18. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
Nischalke HD; Lutz P; Bartok E; Krämer B; Langhans B; Frizler R; Berg T; Hampe J; Buch S; Datz C; Stickel F; Hartmann G; Strassburg CP; Nattermann J; Spengler U
J Mol Med (Berl); 2019 Nov; 97(11):1589-1600. PubMed ID: 31637480
[TBL] [Abstract][Full Text] [Related]
19. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.
Tai J; Hsu CW; Chen WT; Yang SS; Chiu CH; Chien RN; Chang ML
Cancer Sci; 2024 Feb; 115(2):564-574. PubMed ID: 38083881
[TBL] [Abstract][Full Text] [Related]
20. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Lindén D; Ahnmark A; Pingitore P; Ciociola E; Ahlstedt I; Andréasson AC; Sasidharan K; Madeyski-Bengtson K; Zurek M; Mancina RM; Lindblom A; Bjursell M; Böttcher G; Ståhlman M; Bohlooly-Y M; Haynes WG; Carlsson B; Graham M; Lee R; Murray S; Valenti L; Bhanot S; Åkerblad P; Romeo S
Mol Metab; 2019 Apr; 22():49-61. PubMed ID: 30772256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]